Category

VIDEO

Why Does Security Culture Become Complacent, and What Can We Do About It?
TECHNOLOGY, VIDEO

Why Does Security Culture Become Complacent, and What Can We Do About It?

Abie has 25 years of experience in technology, risk, and cybersecurity for complex, multi-stakeholder environments in public and private enterprises. Abie has built cyber programs over several years as a CISO, consulted for many companies, and worked with nationally recognized leaders across the cyber security industry. His recent work has involved rapid cyber and technology transformation of innovative global companies and startups, guiding business resilience and post-breach crisis recovery.

Abie holds a bachelor’s degree in computer science from the University of North Texas and an MBA from Indiana University. He is also a Certified Information Systems Security Professional (CISSP).

Continue reading
Building Maturity Into Your Cybersecurity Program: Strategies for Success
TECHNOLOGY, VIDEO

Building Maturity Into Your Cybersecurity Program: Strategies for Success

Nate Vanderheyden is an Executive Director and Deputy CISO for the U.S. Banks at Morgan Stanley.

Mr. Vanderheyden is responsible for the evaluation and evolution of banking systems to enhance cyber resiliency and defensive measures. He started at the firm in 2018 on the Wealth Management Cybersecurity team in direct support of Global Banking Technology and the Private Bank.

Prior to joining Morgan Stanley, Mr. Vanderheyden served for 11 years in the U.S. Marine Corps and was deployed to Iraq and Afghanistan. His last six years of duty were spent at the National Security Agency (NSA), where he conducted and led a team performing computer network operations, advised senior government officials, and authored multiple policy documents shaping cyberspace operations in support of the U.S. Intelligence Community and national security objectives.

Continue reading
The Cyber Arms Race: How to Stay a Step Ahead of Cyber Crime
TECHNOLOGY, VIDEO

The Cyber Arms Race: How to Stay a Step Ahead of Cyber Crime

Cynthia Kaiser most recently served as a Deputy Assistant Director with the FBI Cyber Division, where she led the Bureau’s cyber threat intelligence, cyber policy, and cyber partner engagement efforts.

Over nearly 20 years with the FBI, Cynthia covered cyber, technology, and counterintelligence issues, served as a PDB Briefer across two presidential administrations, and led FBI cyber threat analysis and election security efforts since 2017. In these roles, she helped reshape the FBI’s information sharing and collaboration with the private sector and with federal, state, and local government officials to be more robust, proactive, and focused on imposing risk and consequences on malicious cyber actors.

Cynthia is also passionate about increasing diversity in cyber and tech professions. She was named a Women Tech Leader Ambassador by GovCIO in 2022, a Top Government Tech Leader to Watch by WashingtonExec in 2023, and received The Cyber Guild’s “Warrior Award” in 2023. She holds a Master’s degree in security policy focused on science and technology and an Executive Master’s degree in leadership.

Continue reading
Software Supply Chain Security: Top 10 Risks & Mitigations
TECHNOLOGY, VIDEO

Software Supply Chain Security: Top 10 Risks & Mitigations

Cassie Crossley, Vice President, Supply Chain Security in the global Cybersecurity & Product Security Office at Schneider Electric, is an experienced cybersecurity technology executive in Information Technology and Product Development and author of “Software Supply Chain Security: Securing the End-to-End Supply Chain for Software, Firmware, and Hardware.” She has many years of business and technical leadership experience in supply chain security, cybersecurity, product/application security, software/firmware development, program management, and data privacy.

Cassie has designed frameworks and operating models for end-to-end security in software development lifecycles, third party risk management, cybersecurity governance, and cybersecurity initiatives. She is a member of the CISA SBOM working groups and presents frequently on the topic of SBOMs and Supply Chain Security.

Cassie has held previous positions at Ceridian, Hewlett-Packard, McAfee, Lotus, and IBM. She has an M.B.A. from California State University, Fresno, and her Bachelor of Science degree in Technical and Professional Communication with a specialization in Computer Science.

Continue reading
Speeding Up Security: How AI and Machine Learning are Revolutionizing Threat Detection and Response
TECHNOLOGY, VIDEO

Speeding Up Security: How AI and Machine Learning are Revolutionizing Threat Detection and Response

Sherrod DeGrippo is Director of Threat Intelligence Strategy at Microsoft. She was selected as Cybersecurity woman of the year in 2022 and Cybersecurity PR Spokesperson of the year for 2021.

Previously, she was VP of Threat Research and Detection at Proofpoint, where she led a global team of threat researchers, malware reverse engineers, and threat intelligence analysts. Her career in cybersecurity spans 19 years with prior roles including leading Red Team Services at Nexum, senior solutions engineer for Symantec, senior security consultant for Secureworks, and senior network security analyst for the National Nuclear Security Administration (NNSA).

She is a frequently cited threat intelligence expert in media including televised appearances on the BBC news, and commentary in the Wall Street Journal, CNN, New York Times, and more. Having presented at Black Hat, Tech Crunch Disrupt, B-Sides Atlanta, RSA conference, RMISC, BrunchCon, and others, Sherrod is a well known public speaker. Currently Sherrod hosts THE Microsoft Threat Intelligence podcast.

In her personal time, Sherrod spends time with her rescue dog Boris Karloff.

Continue reading
Adversity as a Teacher: How Cross-Industry Learnings Can Guide Your Security Evolution
TECHNOLOGY, VIDEO

Adversity as a Teacher: How Cross-Industry Learnings Can Guide Your Security Evolution

Eric is a highly innovative, versatile, and dynamic executive leader with over 20 years of experience in Cybersecurity, Technology Controls, and Third Party Risk Management in the Financial Services Industry, primarily at Global Systemically Important Banks (G-SIBs).

In his current capacity, Eric is the US Chief Information Security Officer (CISO) for TD Bank, America’s Most Convenient Bank (AMCB) and TD Securities (TDS), and is based in Wilmington, Delaware. Prior to joining TD, Eric was the Supplier Assurance Services Executive at JPMorgan Chase & Co., where his organization was responsible for the assessment, continuous monitoring, and third party risk management activities for a highly complex supply chain with teams positioned across the globe. Eric also served as the Head of Cybersecurity for Chase Consumer and Community Banking (CCB), the North America Consumer Bank Group Information Security Officer (GISO) at Citi, and held progressive cybersecurity leadership roles at Bank of America.

Eric is a champion for Diversity, Equity and Inclusion (DE&I) both inside and outside of the organization, including previously serving as the Head of DE&I for Global Supplier Services at JPMorgan Chase & Co., and supporting innovative programs enabling minority suppliers to become cyber-ready to do business within the Financial Services Industry.

Eric is active in the community through board service, and currently serves as the Vice Chairman of the Board for the Delaware Community Reinvestment Action Council (DCRAC). He also serves as the Financial Services representative on the Delaware Cybersecurity Advisory Council, appointed by Governor John Carney in 2018.

Continue reading
Business Risk Impact — Scoring & Analysis
TECHNOLOGY, VIDEO

Business Risk Impact — Scoring & Analysis

Christopher Simm is a dynamic executive leader and Chief Technology Officer at Bulletproof, driving innovation and delivering unparalleled strategic vision. With vast expertise in data center and cloud architecture, Chris has a proven track record of crafting cutting-edge solutions that elevate businesses to new heights. A forward-thinker passionate about progress, he is now spearheading the charge to amplify AI awareness and accelerate digital transformation across the Bulletproof portfolio, empowering clients to thrive in an ever-evolving digital landscape.

Continue reading
TECHNOLOGY, VIDEO

Translating AI Security Investments into Business Value: A BISO’s Guide to Modern Security Operations

Join Owen Burns for a business-focused session on aligning AI-powered security operations with enterprise objectives. Drawing from Fortune 500 case studies, learn how successful BISOs are quantifying the business impact of AI security investments, reducing operational costs, and communicating security value to stakeholders. This session will provide practical frameworks for measuring ROI, managing risk appetite, and building cross-functional support while navigating the transformation to AI-enhanced security operations.

Continue reading
AI in Cybersecurity: A Fireside Chat on Revolutionizing Threat Defense
TECHNOLOGY, VIDEO

AI in Cybersecurity: A Fireside Chat on Revolutionizing Threat Defense

Join us for an intimate fireside chat exploring how Artificial Intelligence is transforming cybersecurity and creating both unprecedented opportunities and complex challenges for today’s leaders. In this candid conversation, Academy Sports and Fortinet will share real-world insights and emerging trends that are reshaping how organizations defend against cyber threats. This isn’t your typical presentation—it’s an open dialogue designed to spark meaningful follow-up discussion about the intersection of AI and cybersecurity.

What You’ll Experience:

Frank discussion about what you need to know about AI and cybersecurity—get beyond the buzzwords and hype
challenges, explore practical solutions, and learn from fellow leaders navigating similar decisions
Strategic insights on future-proofing your organization against evolving threats while harnessing AI’s potential for competitive advantage

Continue reading
Supporting AZ’s Bold Ambition: Scaling Advanced Therapies for Success
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Supporting AZ’s Bold Ambition: Scaling Advanced Therapies for Success

Sheena Behn is an established global leader in the Pharmaceutical Industry with significant supply chain, manufacturing and development experience and expertise. She has worked at AstraZeneca for 25 years.

Sheena is currently VP Vaccine and Immune Therapies Supply Chain and VP for Oncology Supply, based in Cambridge, UK.

She was previously based in Gothenburg as VP R&D Supply Chain (2012-2014) running the global group for Clinical Supply at AZ; and before that VP for Wuxi Manufacturing site for 3 years, based in China (2010-2012).

Sheena is a Pharmacist who started her career working in London hospitals, before working in pharmaceutical development with GSK and then AZ before joining Operations in 2007.

Continue reading
Managing Pharma Supply Chains to Navigate Tariffs
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Managing Pharma Supply Chains to Navigate Tariffs

Allyson Nicholson is a seasoned biopharmaceutical executive with 29 years of experience in end-to-end supply chain management, business reengineering, and digitalization, across a wide range of industries including banking, airline, food, public sector, consulting, and pharmaceutical. Allyson has a proven track record in process improvement, large systems implementations, and mergers and acquisitions. With extensive experience in clinical and commercial supply chains, Allyson has successfully led product commercialization and in-market execution, ensuring supply reliability.

Currently, Allyson serves as the Head of Global Supply Chain at BioMarin Pharmaceutical, where she is responsible for the successful execution and services of all global supply functions ensuring supply to patients for their commercial portfolio and pipeline candidates.

Outside of work she enjoys cooking, learning about wine, skiing and walking in a beach somewhere. She currently lives in Boston with her husband, two young-adult children, and their two dogs.

Continue reading
Transforming Global Operations: Accelerating Production and Innovation at BMS
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Transforming Global Operations: Accelerating Production and Innovation at BMS

Catalina Vargas is Senior Vice President and Global Supply Chain (GSC) Lead at Bristol Myers Squibb (BMS). A global pharmaceutical executive with more than 20 years of experience, Catalina currently leads a talented team, working to seamlessly deliver medicines to patients in more than 50 countries around the world. Under her leadership, Catalina has built a highly synchronized, transparent and sustainable supply chain organization.

Catalina joined BMS in 2018 as Vice President, Strategic Sourcing and Procurement, Global Product Development and Supply, where she managed a complex supply chain to bring critical medicines to patients. During her time in this role, BMS acquired Celgene, which at the time was the largest deal in biopharma history, and Catalina successfully integrated the Celgene and BMS sourcing and procurement groups.

Immediately prior to her current role leading GSC, Catalina was Chief of Staff to the CEO of BMS where she led strategic enterprise-wide initiatives and advanced the leadership team’s governance and decision-making model. With an exceptional record of building high performing and agile global teams, Catalina is a passionate advocate for inclusion.

Prior to joining BMS, Catalina was with Pfizer for 17 years, where she was tapped for leadership positions across strategic sourcing, operations, and external manufacturing.

Catalina has a bachelor’s degree in industrial engineering and a graduate degree in finance and capital markets.

Continue reading
Resilient Operations in a Changing World: Innovation with Purpose
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Resilient Operations in a Changing World: Innovation with Purpose

Arleen Paulino, senior vice president, Manufacturing, leads Amgen’s commercial manufacturing organization. Prior to this role, Paulino served as vice president, Site Operations at Amgen Singapore Manufacturing from 2016 to 2018, where she led the team to the successful licensure of Amgen’s first Next-Generation Biomanufacturing plant.

Paulino joined Amgen in 2002 and over the years has held various positions with increasing responsibility in Process Engineering and Process Development. She was also the head of Clinical Operations and Development Supply Chain, where she was responsible for the end-to-end supply chain for the manufacture and delivery of clinical product to support Amgen’s global clinical trials.

She began her career in Operations at Genentech and later joined Immunex, where she held a variety of roles overseeing development and scale-up operations, contract manufacturing and technology transfer, as well as plant manager for the cell culture facility.

Paulino holds a Bachelor of Science degree in Biochemistry from Marquette University.

Continue reading
From Platform Excellence to Personalized Oncology: Shaping the Next Era of mRNA Science and Manufacturing at Moderna
LIFE SCIENCES, VIDEO, LIFE SCIENCES

From Platform Excellence to Personalized Oncology: Shaping the Next Era of mRNA Science and Manufacturing at Moderna

As Chief Technical Operations and Quality Officer, Dr. Collins is responsible for the technical development, quality, and supply of preclinical, clinical and commercial programs within Moderna’s portfolio.

Dr. Collins joined Moderna from Novartis, where he held roles of increasing responsibility over the last nearly 30 years, focused on pharmaceutical production and manufacturing, including roles serving as Head of Global Chemical Operations and Anti-Infectives and as Head of Global Chemical Operations.

Dr. Collins received his Bachelor of Science in Chemistry and his Ph.D. in Organic Chemistry from University College Cork, Ireland. He also conducted post-doctoral cancer research at Arizona State University.

Continue reading
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Regulatory Instability’s Impact on Drug and Biologics Manufacturing

Alexander Gaffney is a regulatory and media executive responsible for founding and leading the research division of AgencyIQ, the regulatory analysis division of the media company POLITICO. As the Vice President of Regulatory Policy and Intelligence, Alexander directs the division’s analysis of regulatory issues affecting pharmaceutical, biotechnology, medical device, chemical and food companies.

Before joining AgencyIQ, Alexander analyzed life sciences regulations as part of PricewaterhouseCoopers’s Health Research Institute and was the Manager of Regulatory Intelligence at the Regulatory Affairs Professionals Society (RAPS), where he also served as Managing Editor for the company’s flagship publication, Regulatory Focus.

Alexander is regularly asked to speak to executive audiences about life science regulatory policy developments and his analysis and work (including his daily newsletter, FDA Today) is relied upon by many of the country’s top life sciences companies, law firms, trade associations, regulatory professionals, legislative staffers and public health officials. He has a master’s degree in Regulatory Science from the University of Maryland and his Regulatory Affairs Certification (RAC) in US regulation. He also serves as the co-chair of the Drug Information Association’s (DIA) Regulatory Policy and Intelligence Community and the Chair of RAPS’ Regulatory Intelligence Conference.

Continue reading
Bold and Unafraid: Lessons in Leadership and the Value of Manufacturing in Building the Next Great Biotech
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Bold and Unafraid: Lessons in Leadership and the Value of Manufacturing in Building the Next Great Biotech

Tim Maines joined Alnylam in August 2017 as the Global Head of Quality Assurance and Quality Control and was promoted to Chief Technical Operations and Quality Officer in April of 2023, holding over 35 years of experience. Prior to joining Alnylam, Tim was a member of the senior leadership teams at Ariad Pharmaceuticals, Omthera Pharmaceuticals, Astra Zeneca/MedImmune, GTC Biotherapeutics (formerly Genzyme Transgenics) and Stryker Biotech where he provided strategic input and independent quality and technical oversight of each company’s global GxP operations. In total, these experiences resulted with the commercialization and market expansion of thirteen novel medicines, including four FDA-approved therapies at Alnylam.

Tim holds a Bachelor of Science in Biology/Microbiology from Gannon University.

Continue reading
Panel: Reflecting on the Past and Shaping the Future: Enhancing Our Influence on Medicine
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Panel: Reflecting on the Past and Shaping the Future: Enhancing Our Influence on Medicine

Evaluating which production platforms will be most effective for emerging modalities, such as rAAV gene therapies
Considering the next steps for established platforms like mAbs, ADCs, and mRNA: How can we efficiently address significant markets, such as treatments for Alzheimer’s
Examining the changes within the CMC ecosystem and assessing whether we are once again overextending our capacity
Addressing the risks of fragmentation: How can we improve communication, collaboration, and the consolidation of our best ideas to ensure collective success?
Discussing the motivations for launching new companies today and envisioning the future growth and evolution of our business ecosystem

Continue reading